Shanghai OPM Biosciences Future Growth
Future criteria checks 5/6
Shanghai OPM Biosciences is forecast to grow earnings and revenue by 60% and 36.6% per annum respectively. EPS is expected to grow by 59.9% per annum. Return on equity is forecast to be 7.6% in 3 years.
Key information
60.0%
Earnings growth rate
59.9%
EPS growth rate
| Biotechs earnings growth | 43.4% |
| Revenue growth rate | 36.6% |
| Future return on equity | 7.6% |
| Analyst coverage | Low |
| Last updated | 31 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 667 | 198 | 24 | 208 | 3 |
| 12/31/2025 | 498 | 136 | -38 | 124 | 3 |
| 12/31/2024 | 349 | 77 | 13 | 134 | 3 |
| 9/30/2024 | 287 | 38 | -29 | 83 | N/A |
| 6/30/2024 | 265 | 40 | -46 | 62 | N/A |
| 3/31/2024 | 255 | 49 | -31 | 59 | N/A |
| 12/31/2023 | 243 | 54 | -20 | 58 | N/A |
| 9/30/2023 | 243 | 65 | -78 | 52 | N/A |
| 6/30/2023 | 269 | 90 | -39 | 103 | N/A |
| 3/31/2023 | 290 | 104 | -28 | 114 | N/A |
| 12/31/2022 | 294 | 105 | -35 | 112 | N/A |
| 9/30/2022 | 285 | 97 | -2 | 134 | N/A |
| 6/30/2022 | 277 | 95 | -5 | 111 | N/A |
| 3/31/2022 | 244 | 76 | -10 | 105 | N/A |
| 12/31/2021 | 213 | 60 | 9 | 115 | N/A |
| 12/31/2020 | 125 | 12 | -33 | 3 | N/A |
| 12/31/2019 | 59 | -12 | -3 | 17 | N/A |
| 12/31/2018 | 34 | -42 | -55 | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688293's forecast earnings growth (60% per year) is above the savings rate (2.8%).
Earnings vs Market: 688293's earnings (60% per year) are forecast to grow faster than the CN market (26.1% per year).
High Growth Earnings: 688293's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688293's revenue (36.6% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 688293's revenue (36.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688293's Return on Equity is forecast to be low in 3 years time (7.6%).